Drug Information

Drug General Information
Drug ID
D08NIN
Former ID
DIB008668
Drug Name
NN-9926
Synonyms
NNC-0113-0987
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Phase 1 [523566]
Company
Novo Nordisk A/S
Target and Pathway
Target(s) Glucagon-like peptide 1 receptor Target Info Agonist [551911]
KEGG Pathway cAMP signaling pathway
Neuroactive ligand-receptor interaction
Insulin secretion
Reactome Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
G alpha (s) signalling events
Glucagon-type ligand receptors
WikiPathways GPCRs, Class B Secretin-like
Integration of energy metabolism
GPCR ligand binding
GPCR downstream signaling
References
Ref 523566ClinicalTrials.gov (NCT01405261) Trial Investigating the Safety of NNC 0113-0987 in Healthy Male Subjects. U.S. National Institutes of Health.
Ref 551911Clinical pipeline report, company report or official report of Addex Pharmaceuticals.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.